Literature DB >> 25551235

The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review.

Vanessa C Evans1, Grant L Iverson, Lakshmi N Yatham, Raymond W Lam.   

Abstract

OBJECTIVE: Neurocognitive deficits are demonstrated in major depressive disorder (MDD) and most likely contribute to the functional impairment experienced by affected individuals. We systematically reviewed the evidence on neurocognitive deficits and their relationship(s) to psychosocial functioning in MDD. DATA SOURCES: English-language literature was searched in MEDLINE, EMBASE, Science Direct, and PsycInfo databases for the years 1980-October 15, 2013, with the following terms: (depressive disorder or depressive disorder, major) and permutations of (cognitive, neurocognitive, neuropsych*) with (impairment, deficit, performance, test) and (quality of life; functional outcomes; outcome assessment, health care) or (assessment, outcomes; assessment, patient outcomes; outcomes assessment; outcomes assessments, patient). STUDY SELECTION: Inclusion criteria were (1) nongeriatric adults (< 60 years) with a primary diagnosis of MDD by DSM-IV, ICD-9, or ICD-10 criteria; (2) use of neuropsychological tests; and (3) use of a specific measure of social, occupational, or daily functioning. Of 488 articles identified in the initial search, 10 met the inclusion criteria. DATA EXTRACTION: Two independent appraisers assessed eligibility of the studies. Substantial heterogeneity in the samples and methods precluded a quantitative meta-analysis, so we performed a narrative descriptive review.
RESULTS: The included studies employed a variety of neurocognitive tests and assessments of psychosocial functioning. Overall, depressed samples had neurocognitive deficits in various domains that were associated with different measures of psychosocial functioning. However, these findings were constrained by methodological limitations of studies.
CONCLUSIONS: The limited evidence base suggests that neurocognitive functioning appears to be broadly associated with functional impairment in individuals with MDD, but the quality of evidence is weak. Further studies to clarify the relationship(s) between neurocognitive and psychosocial functioning in MDD will benefit from larger and more homogeneous samples, prospective designs with multivariate analyses, and use of comprehensive assessments of psychosocial functioning that are validated in depressed populations. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25551235     DOI: 10.4088/JCP.13r08939

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  47 in total

Review 1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.

Authors:  Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

2.  Health-related quality of life in remitted psychotic depression.

Authors:  Kathleen S Bingham; Ellen M Whyte; Benoit H Mulsant; Anthony J Rothschild; Matthew V Rudorfer; Patricia Marino; Samprit Banerjee; Meryl A Butters; George S Alexopoulos; Barnett S Meyers; Alastair J Flint
Journal:  J Affect Disord       Date:  2019-05-28       Impact factor: 4.839

3.  Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders.

Authors:  Daniel W Chung; Youjin Chung; H Holly Bazmi; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2018-08-02       Impact factor: 7.853

4.  In pursuit of full recovery in major depressive disorder.

Authors:  Vicent-Gil M; Serra-Blasco M; Navarra-Ventura G; Trujols J; Balanzá-Martínez V; Portella Mj; Cardoner N
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-09       Impact factor: 5.760

5.  Imbalance in subregional connectivity of the right temporoparietal junction in major depression.

Authors:  Timm B Poeppl; Veronika I Müller; Felix Hoffstaedter; Danilo Bzdok; Angela R Laird; Peter T Fox; Berthold Langguth; Rainer Rupprecht; Christian Sorg; Valentin Riedl; Roberto Goya-Maldonado; Oliver Gruber; Simon B Eickhoff
Journal:  Hum Brain Mapp       Date:  2016-04-19       Impact factor: 5.038

6.  Association Between Muscular Strength and Cognition in People With Major Depression or Bipolar Disorder and Healthy Controls.

Authors:  Joseph Firth; Josh A Firth; Brendon Stubbs; Davy Vancampfort; Felipe B Schuch; Mats Hallgren; Nicola Veronese; Alison R Yung; Jerome Sarris
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

7.  Understanding cognitive impairment in mood disorders: mediation analyses in the UK Biobank cohort.

Authors:  Breda Cullen; Daniel J Smith; Ian J Deary; Jill P Pell; Katherine M Keyes; Jonathan J Evans
Journal:  Br J Psychiatry       Date:  2019-11       Impact factor: 9.319

Review 8.  Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.

Authors:  Raymond W Lam; Sidney H Kennedy; Roger S Mclntyre; Atul Khullar
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

9.  Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1.

Authors:  Shane J McInerney; Trisha Chakrabarty; Malgorzata Maciukiewicz; Benicio N Frey; Glenda M MacQueen; Roumen V Milev; Arun V Ravindran; Susan Rotzinger; Sidney H Kennedy; Raymond W Lam
Journal:  Can J Psychiatry       Date:  2020-12-23       Impact factor: 4.356

10.  Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.

Authors:  Trisha Chakrabarty; Shane J McInerney; Ivan J Torres; Benicio N Frey; Roumen V Milev; Daniel J Müller; Susan Rotzinger; Sidney H Kennedy; Raymond W Lam
Journal:  CNS Drugs       Date:  2021-03-08       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.